Steven R. Deitcher, M.d
Founder, President, CEO, and Board Member
United States of America
Dr. Deitcher is an innovative business leader who has more than 25 years of life science product development experience including cellular therapeutics, biologics, small molecules, and diagnostics. He was President, CEO and Board Member at Talon Therapeutics, a specialty biopharmaceutical company focused on novel cancer drug delivery. At Talon, his team advanced its lead compound, Marqibo®, from IND to FDA accelerated approval to treat leukemia and positioned the company for sale to Spectrum Pharmaceuticals. He previously served as Vice President and Chief Medical Scientist at Nuvelo. He was formerly the Chief of Hematology and Director of Thrombosis and Vascular Medicine Research at The Cleveland Clinic and held leadership positions at The University of Tennessee Health Science Center and St. Jude Children’s Research Hospital. He received his B.S. and M.D. in the Honors Program in Medical Education at Northwestern University. He is a member of several corporate and university advisory boards and has authored 225 publications in medical and scientific journals.
cellular therapeutics, biologics, small molecules, and diagnostics